Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

By sjmartinez • February 4, 2025

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan SY, Phillip Koeffler H, Ding L, Chen YQ, Feng N. Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study. Br J Cancer. 2025 Feb 3. doi: 10.1038/s41416-025-02947-0. Epub ahead of print. PMID: 39900986.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Characterizing longitudinal blood pressure trajectories in patients at high risk for de novo postpartum hypertension: A randomized controlled trial secondary analysis

Emeruwa UN, Sarker MR, Bello N, Jacobs M, Laurent LC, Teal EN, Wen T, Miller RS, Gyamfi-Bannerman C. Characterizing longitudinal blood pressure trajectories in patients[...]

Advancing biological understanding of cellular senescence with computational multiomics

Li S, Agudelo Garcia PA, Aliferis C, Becich MJ, Calyeca J, Cosgrove BD, Elisseeff J, Farzad N, Fertig EJ, Glass C, Gu L, Hu Q,[...]

Ectopic adipose tissue in subsistence populations with minimal coronary disease, large left atria, and very low rates of atrial fibrillation

Thompson RC, Trumble BC, Cummings DK, Neunuebel AD, Hooper PL, Wann S, Allam AH, Neunuebel F, Gans BD, King SI, Seabright E, Finch CE, Gatz[...]